Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection (Q37860816)

24 August 2017

1 reference

title

Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection (English)

1 reference

24 August 2017

0 references

0 references

1 reference

Victor Herrera

1

1 reference

24 August 2017

Sharon Perry

series ordinal

2

1 reference

24 August 2017

Julie Parsonnet

series ordinal

3

1 reference

24 August 2017

Niaz Banaei

series ordinal

4

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 April 2011

1 reference

Clinical Infectious Diseases

24 August 2017

1 reference

24 August 2017

52

1 reference

24 August 2017

1031-1037

1 reference

24 August 2017

8

1 reference

Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000.

24 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Prevalence of tuberculin skin test positivity in clinical population in New York City.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

The epidemiology of tuberculosis among primary refugee arrivals in Minnesota between 1997 and 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Specific immune-based diagnosis of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Influence of the Prevalence of Infection on Tuberculin Skin Testing Programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot.TB test in contact investigations for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

IFNgamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

The prognosis of latent tuberculosis: can disease be predicted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Short-term reproducibility of a commercial interferon gamma release assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Dynamic Antigen-specific T-Cell Responses after Point-Source Exposure toMycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Immediate incubation reduces indeterminate results for QuantiFERON-TB Gold in-tube assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Serial testing of health care workers for tuberculosis using interferon-gamma assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Commercial interferon gamma release assays compared to the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection in childhood contacts in the Gambia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Interferon-gamma release assays: new diagnostic tests for Mycobacterium tuberculosis infection, and their use in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

21 January 2018

Paediatric tuberculosis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Reproducibility of QuantiFERON-TB gold in-tube assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Do results of the T-SPOT.TB interferon-gamma release assay change after treatment of tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Evaluation of the prognostic value of IFN-gamma release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

Priorities for the Treatment of Latent Tuberculosis Infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIR068

21 January 2018

Identifiers

DOI

10.1093/CID/CIR068

1 reference

24 August 2017

1 reference